1. Home
  2. IDYA vs TNET Comparison

IDYA vs TNET Comparison

Compare IDYA & TNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$36.76

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Logo TriNet Group Inc.

TNET

TriNet Group Inc.

HOLD

Current Price

$65.17

Market Cap

3.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDYA
TNET
Founded
2015
1988
Country
United States
United States
Employees
N/A
3400
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.0B
IPO Year
2019
2000

Fundamental Metrics

Financial Performance
Metric
IDYA
TNET
Price
$36.76
$65.17
Analyst Decision
Strong Buy
Hold
Analyst Count
16
5
Target Price
$52.86
★ $65.80
AVG Volume (30 Days)
★ 661.4K
265.2K
Earning Date
05-06-2026
04-30-2026
Dividend Yield
N/A
★ 2.57%
EPS Growth
★ 61.90
N/A
EPS
N/A
★ 3.05
Revenue
$218,710,000.00
★ $5,010,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$201.05
$3.30
P/E Ratio
★ N/A
$21.49
Revenue Growth
★ 3024.43
N/A
52 Week Low
$26.05
$33.67
52 Week High
$42.68
$73.08

Technical Indicators

Market Signals
Indicator
IDYA
TNET
Relative Strength Index (RSI) 41.90 43.08
Support Level $34.74 $64.84
Resistance Level $38.37 $71.56
Average True Range (ATR) 1.28 1.89
MACD -0.28 -0.47
Stochastic Oscillator 29.25 21.28

Price Performance

Historical Comparison
IDYA
TNET

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About TNET TriNet Group Inc.

Trinet Group Inc provides human resources solutions for small and medium-sized businesses through technology-enabled services. Its offerings include human capital expertise, employee benefits such as health insurance and retirement plans, payroll and payroll tax administration, risk mitigation, and compliance consulting. The company provides its services through professional employer organization (PEO) services delivered via a co-employment model, as well as administrative services organization (ASO) offerings. The majority of the company's revenue is derived from the insurance-related billings and administrative fees collected from PEO clients.

Share on Social Networks: